24 employees
Drug discovery, AI, ML, Bioinformatics, Chemistry, Research & Development, Medicinal Chemistry , small molecules, retrosynthesis,
2019
Boltzmann raised undisclosed on April 1, 2022
Investors: GSD Venture Studios